The latest news, blogs, reports, explainers and commentaries of the COG-UK consortium



19 Jan 2021

New SARS-CoV-2 variant & other mutations under review

A brief summary of the latest COG-UK mutational surveillance report, which explores SARS-CoV-2 spike gene mutations of potential or known importance.


13 Jan 2021

Asymptomatic screening & genome sequencing help understand SARS-CoV-2

Initial results suggest that University of Cambridge's screening programme, along with public health measures and student behaviour, has limited the spread of the virus.


7 Jan 2021

‘World-class’ CLIMB project receives £1.2 million funding boost from UKRI

As part of a wider investment to expand and upgrade ‘world-class’ research infrastructure, the CLIMB project has received a £1.2 million funding boost from UKRI.


18 Dec 2020

Watch the first COG-UK Showcase Event

On the 16th December, we presented our first Showcase Event: SARS-CoV-2 sequencing to inform clinical care, public health interventions and policy decisions. Watch the recording of the event here.


18 Dec 2020

Persistent SARS-CoV-2 infection & viral evolution tracked in an immuno-compromised patient

All viruses accumulate mutations as they evolve over time. But what are the drivers of viral evolution, and could antibody treatment have any influence on this process?


17 Dec 2020

A short history of the COVID-19 Genomics UK (COG-UK) Consortium

This short history of the development of the COG-UK consortium is dedicated to everyone who has contributed to its success, with unlimited energy, enthusiasm, commitment and support.


14 Dec 2020

Update on new SARS-CoV-2 variant and how COG-UK tracks emerging mutations

Since its creation COG-UK has been supporting genomic surveillance efforts to identify variants of the SARS-CoV-2 virus in the genome sequencing data from the UK.


9 Dec 2020

Genomic analysis of epidemic waves of COVID-19 in Scotland and Wales

Two reports submitted to SAGE describe the genomic history of SARS-CoV-2 in Scotland and Wales throughout the first epidemic wave, and into the second.